These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
532 related articles for article (PubMed ID: 31048854)
1. Brain metastases in resected non-small cell lung cancer: The impact of different tyrosine kinase inhibitors. Yun PJ; Wang GC; Chen YY; Wu TH; Huang HK; Lee SC; Chang H; Huang TW PLoS One; 2019; 14(5):e0215923. PubMed ID: 31048854 [TBL] [Abstract][Full Text] [Related]
2. Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases. Yu X; Sheng J; Pan G; Fan Y Int J Cancer; 2021 Sep; 149(5):1121-1128. PubMed ID: 33970485 [TBL] [Abstract][Full Text] [Related]
3. Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational study. Chen YH; Chen YF; Chen CY; Shih JY; Yu CJ BMC Cancer; 2019 Oct; 19(1):1006. PubMed ID: 31655564 [TBL] [Abstract][Full Text] [Related]
4. EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases. Jiang T; Su C; Li X; Zhao C; Zhou F; Ren S; Zhou C; Zhang J J Thorac Oncol; 2016 Oct; 11(10):1718-28. PubMed ID: 27237825 [TBL] [Abstract][Full Text] [Related]
5. EGFR inhibitors as adjuvant therapy for resected non-small cell lung cancer harboring EGFR mutations. Tang W; Li X; Xie X; Sun X; Liu J; Zhang J; Wang C; Yu J; Xie P Lung Cancer; 2019 Oct; 136():6-14. PubMed ID: 31421260 [TBL] [Abstract][Full Text] [Related]
6. Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis. Zhang Q; Zhang X; Yan H; Jiang B; Xu C; Yang J; Chen Z; Su J; Wu YL; Zhou Q Thorac Cancer; 2016 Nov; 7(6):648-654. PubMed ID: 27755835 [TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of adjuvant EGFR-TKIs for patients with resected non-small cell lung cancer. Cheng H; Li XJ; Wang XJ; Chen ZW; Wang RQ; Zhong HC; Wu TC; Cao QD Lung Cancer; 2019 Nov; 137():7-13. PubMed ID: 31520922 [TBL] [Abstract][Full Text] [Related]
8. Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs. Gui Q; Liu J; Li D; Xu C World J Surg Oncol; 2017 Oct; 15(1):184. PubMed ID: 29037198 [TBL] [Abstract][Full Text] [Related]
9. [Timing of Whole Brain Radiotherapy on Survival of Patients with EGFR-mutated Non-small Cell Lung Cancer and Brain Metastases]. Liu G; Zhang X; Tian C; Xia G; Liu P; Zhang Q; Li X; Zhang H; Qin N; Wang J; Zhang S Zhongguo Fei Ai Za Zhi; 2016 Aug; 19(8):501-7. PubMed ID: 27561798 [TBL] [Abstract][Full Text] [Related]
10. [Survival analysis of different kinds of tyrosine kinase inhibitors in the treatment of patients with epidermal growth factor receptor mutated non-small cell lung cancer and leptomeningeal metastasis]. Xu HY; Chen HQ; Kong JX; Zhang Y; Liu S; Yang GJ; Wang Y Zhonghua Yi Xue Za Zhi; 2022 Feb; 102(6):399-405. PubMed ID: 35144338 [No Abstract] [Full Text] [Related]
11. Adjuvant Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (TKIs) in Resected Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-analysis. Raphael J; Vincent M; Boldt G; Shah PS; Rodrigues G; Blanchette P Am J Clin Oncol; 2019 May; 42(5):440-445. PubMed ID: 30913091 [TBL] [Abstract][Full Text] [Related]
12. Relative Efficacies of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for Treatment of Recurrent Non-Small Cell Lung Cancer after Surgery. Motono N; Mizoguchi T; Ishikawa M; Iwai S; Iijima Y; Uramoto H Oncology; 2024; 102(6):476-483. PubMed ID: 37984347 [TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates enhance antitumor effect of EGFR-TKIs in patients with advanced EGFR mutant NSCLC and bone metastases. Zhang G; Cheng R; Zhang Z; Jiang T; Ren S; Ma Z; Zhao S; Zhou C; Zhang J Sci Rep; 2017 Feb; 7():42979. PubMed ID: 28211502 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients harboring different types of EGFR mutations: A retrospective analysis. Liu HL; Han G; Peng M; Weng YM; Yuan JP; Yang GF; Yu JM; Song QB J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):864-872. PubMed ID: 29270745 [TBL] [Abstract][Full Text] [Related]
15. EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastases. Jiang T; Zhang Y; Li X; Zhao C; Chen X; Su C; Ren S; Yang N; Zhou C Eur J Cancer; 2019 Nov; 121():98-108. PubMed ID: 31569068 [TBL] [Abstract][Full Text] [Related]
16. Optimal sequence of LT for symptomatic BM in EGFR-mutant NSCLC: a comparative study of first-line EGFR-TKIs with/without upfront LT. Niu L; Wu H; Gao R; Chen L; Wang J; Duan H; Long Y; Xie Y; Zhou Q; Zhou R J Cancer Res Clin Oncol; 2024 Feb; 150(2):94. PubMed ID: 38369644 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis. Byeon S; Ham JS; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ Med Oncol; 2016 Aug; 33(8):97. PubMed ID: 27447711 [TBL] [Abstract][Full Text] [Related]
18. Optimal Adjuvant Therapy in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer Harboring EGFR Mutations. Wen M; Wang L; Wang X; Yang S; Sun Y; Xia J; Zhang Y; Zhang Z; Huang L; Jiang T Oncol Res Treat; 2020; 43(12):686-693. PubMed ID: 33197924 [TBL] [Abstract][Full Text] [Related]
19. Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer. Tan CS; Cho BC; Soo RA Lung Cancer; 2016 Mar; 93():59-68. PubMed ID: 26898616 [TBL] [Abstract][Full Text] [Related]
20. Impacts of EGFR mutation and EGFR-TKIs on incidence of brain metastases in advanced non-squamous NSCLC. Wang BX; Ou W; Mao XY; Liu Z; Wu HQ; Wang SY Clin Neurol Neurosurg; 2017 Sep; 160():96-100. PubMed ID: 28704781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]